Delivery Order W91YU015D0010-W81K0220F0131
- Not listed
- Gen-Probe Incorporated, operating through its Gen-Probe Sales & Service division, has been awarded a $16.2 million firm fixed price delivery order contract by the Department of the Army Medical Command to provide COVID-19 PANTHER Fusion test kits. The test kits will support the Army's medical response to the coronavirus pandemic and will be delivered to a facility in Fort Sam Houston, Texas. No subcontractors or set aside designations were identified. The contract was funded under the Army's...
- This federal contract award is for a minimum guarantee delivery order with a firm fixed price of $456,519.00, issued by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company. The award does not have a set-aside designation. Through this contract, Gen-Probe Incorporated will provide a variety of goods and services, including APTIMA combo assay test kits for chlamydia and gonorrhea, APTIMA HIV-1 and hepatitis C virus tests, PANTHER FUSION systems and...
- This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...
- The Department of the Army Medical Command awarded a $19.5 million delivery order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for PANTHER FUSION SARS-COV-2 PRIMER PROBE MIX AND CONSUMABLE ITEMS. The products will support the Army's COVID-19 response efforts and will be delivered to a location in San Antonio, Texas under the firm fixed price contract scheduled to run from April 2020 through April 2021. No set aside designation or subcontractors were indicated. The award...
- This firm fixed-price purchase order was awarded by the Medical Command (MEDCOM) component of the U.S. Army to Gen-Probe Incorporated, a large medical diagnostics company, for the provision of nucleic acid probe test kits. The $1,550,250.00 contract has an ultimate completion date of September 30, 2020. Gen-Probe Incorporated, the prime contractor, is a for-profit organization that specializes in molecular diagnostic testing systems, assays, and related products and services for the U.S. federal...
- The Department of the Army Medical Command awarded Gen-Probe Incorporated, a medical diagnostics company, a $330,000.00 firm fixed price purchase order for the PANTHER INSTRUMENT SYSTEM. This contract is not set aside and is related to the Coronavirus COVID-19 national interest action. Gen-Probe Incorporated has previously provided a variety of medical testing systems and assays, including for infectious diseases, to federal agencies such as the Defense Health Agency, Department of Veterans...
- This federal contract award, valued at $1,265,955.00, was issued by the United States Army Medical Command (MEDCOM) to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of APTIMA COMBO 2, 250-TEST KIT, PANTHER systems. The contract is a firm fixed-price purchase order with a completion date of September 30, 2018. Gen-Probe Incorporated is a prime contractor that has held numerous contracts with defense and civilian agencies, primarily supplying testing kits, reagents,...
- The Department of the Army Medical Command awarded a firm-fixed-price purchase order to Gen-Probe Incorporated, a medical diagnostics company, for the PANTHER FUSION SYSTEM - LABORATORY TESTING FOR COVID-19. The award, with a potential value of $239,000.00, does not have a set-aside designation. The original solicitation requested virtual health equipment, including examination cameras, stethoscopes, headphones, webcams, and emergency response kits, for the telehealth department at Landstuhl...
- This federal contract award, valued at $25,000.00, was issued by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of PANTHER COVID-19 testing supplies. The contract is a purchase order with a firm fixed price and does not have a set-aside designation. Gen-Probe Incorporated is a key supplier of molecular diagnostic testing systems, assays, and related products and services to various federal agencies, including the Department of Defense,...
- This is a $319,600 firm-fixed-price delivery order awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, for COVID-19 testing reagents and the APTIMA SARS-CoV-2 assay. The award does not have a set-aside designation. Gen-Probe has held numerous federal contracts, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases to defense and civilian agencies. This delivery order is part of a larger $15 million...
- W91YU015D0010Indefinite Delivery Contract
- W91YU015D0010-W81K0220F0131Delivery Order
This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, is for the delivery of PANTHER FUSION SARS-COV2 ASSAY PPR SOLUTION (test kits) and DNA/RNA ENZYME CARTRIDGE (reagent) kits in support of the COVID-19 response. The $1,800,000.00 firm fixed-price delivery order was issued by the Medical Command (MEDCOM) of the U.S. Department of the Army. The contract has no set-aside designation. Gen-Probe, a large specialized supplier in molecular diagnostics, has held numerous federal contracts to provide testing kits, reagents, and equipment to defense and civilian agencies. This award is part of the company's broader work supporting the government's COVID-19 pandemic response, including supplying millions of dollars worth of SARS-CoV-2 assays and testing systems under the Coronavirus national interest action code. The Department of the Army has also leveraged Gen-Probe's indefinite delivery contracts and blanket purchase agreements to quickly procure critical molecular diagnostic products for military personnel and their families.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Microbiology Testing at Madigan Army Medical Center (MAMC) | W91YU015T0142 | Department of the Army Medical Command | Award Notice 1/1 | 6/17/15, 10:37 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8m | 4/24/20 |